Abstract
In order to understand the mechanism underlying in dyslipoproteinemia accompanied with liver diseases, levels in apolipoproteins A-I, C-III and E mRNA expressions in various human parenchymal liver diseases were assessed by Northen blot analysis. The mRNA expressions were significantly decreased in liver cirrhosis and acute hepatitis as compared with controls and were correlated with serum albumin levels. This finding indicates that liver biosynthesis of these apolipoproteins is suppressed in parenchymal human liver disease. This could be one of the mechanisms causing the dyslipoproteinemia in the liver diseases. This is the first study to show decreased apolipoprotein gene expression in human parenchymal liver diseases.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
